Contrasting effects of PACAP and carbachol on [Ca2+]i and inositol phosphates in human neuroblastoma NB-OK-1 cells

Peptides. 1993 Nov-Dec;14(6):1111-8. doi: 10.1016/0196-9781(93)90163-b.

Abstract

The effects of PACAPs on [Ca2+]i were compared to those of carbachol in human neuroblastoma NB-OK-1 cells. PACAP(1-27) and PACAP(1-38) increased [Ca2+]i in a biphasic manner: a transient rise and a secondary plateau. The transient phase reflected the mobilization of [Ca2+]i pool(s) via the inositol phosphate pathway. The modest sustained plateau required extracellular Ca2+. Carbachol also increased [Ca2+]i in a biphasic manner, but it mobilized intracellular Ca2+ pool(s) with a higher efficacy than PACAPs, then greatly increased Ca2+ entry, this being accompanied by a more marked and prolonged elevation of IP3 and IP4 than with PACAPs. It is likely that cAMP-mediated phosphorylations due to PACAPs facilitated desensitization at the PACAP receptor-phospholipase C level, so that there was less Ca2+ handling through PACAP receptors than with muscarinic M1 receptors.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Calcium / metabolism*
  • Carbachol / pharmacology*
  • Colforsin / pharmacology
  • Egtazic Acid / pharmacology
  • Humans
  • Inositol Phosphates / metabolism*
  • Neuroblastoma
  • Neurons / drug effects*
  • Neuropeptides / pharmacology*
  • Peptide Fragments / pharmacology
  • Pituitary Adenylate Cyclase-Activating Polypeptide
  • Potassium / pharmacology
  • Tumor Cells, Cultured

Substances

  • ADCYAP1 protein, human
  • Inositol Phosphates
  • Neuropeptides
  • Peptide Fragments
  • Pituitary Adenylate Cyclase-Activating Polypeptide
  • pituitary adenylate-cyclase-activating-peptide (6-38)
  • Colforsin
  • Egtazic Acid
  • Carbachol
  • Potassium
  • Calcium